Cromakalim

A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. (Martindale, The Extra Pharmacopoeia, 30th ed, p352)

Also Known As:

Levcromakalim; BRL-34915; BRL-38226; BRL-38227; Cromakalim, (3R-cis)-Isomer; Cromakalim, (3R-trans)-Isomer; Cromakalim, (3S-cis)-Isomer; Cromakalim, (3S-trans)-Isomer; Cromakalim, (trans)-Isomer; Lemakalim; BRL 38226; BRL 38227; BRL38226; BRL38227; 2H-1-Benzopyran-6-carbonitrile, 3,4- dihydro- 3- hydroxy- 2,2- dimethyl- 4- (2- oxo- 1- pyrrolidinyl)- , trans-(+-)-

Pharmalogical Action Categories:

Antihypertensive Agents
Bronchodilator Agents
Parasympatholytics
Vasodilator Agents

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Pyrroles: 381
      - Cromakalim: 289
  - Pyrans: 131
    - Benzopyrans: 198
      - Cromakalim: 289
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 198
      - Cromakalim: 289

P G Sleph Selected Research

P G Sleph Research Topics

Disease

Drug/Important Bio-Agent (IBA)